Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone

T2 glottic cancer with impaired vocal cord mobility (T2b) is known to have higher local failure rates when compared with T2 cancers without impaired cord mobility (T2a) treated with radiotherapy (RT) alone.

[1]  Christopher U. Jones,et al.  Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512). , 2014, International journal of radiation oncology, biology, physics.

[2]  Christopher U. Jones,et al.  Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer. , 2014, International journal of radiation oncology, biology, physics.

[3]  A. Al-Mamgani,et al.  Radiotherapy for T1‐2N0 glottic cancer: a multivariate analysis of predictive factors for the long‐term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients , 2013, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[4]  R. Weber,et al.  Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Reddy,et al.  Definitive radiotherapy for early (T1-T2) Glottic Squamous cell carcinoma: a 20 year Cleveland clinic experience , 2012, Radiation oncology.

[6]  Y. Horikawa,et al.  Multi-Institutional Analysis of Early Glottic Cancer from 2000 to 2005 , 2012, Radiation oncology.

[7]  W. Mendenhall,et al.  Prognostic Significance of Paraglottic Space Invasion in T2N0 Glottic Carcinoma , 2007, American journal of clinical oncology.

[8]  K. Ang,et al.  American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Y. Kitamoto,et al.  Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. , 2006, International journal of radiation oncology, biology, physics.

[10]  L. Livi,et al.  Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. , 2005, International journal of radiation oncology, biology, physics.

[11]  A. Garden,et al.  Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? , 2003, International journal of radiation oncology, biology, physics.

[12]  A. Hanlon,et al.  Neck failure in T2N0 squamous cell carcinoma of the true vocal cords: the Fox Chase experience and review of the literature. , 1997, American journal of clinical oncology.

[13]  K. Greven,et al.  Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. , 1997, International journal of radiation oncology, biology, physics.

[14]  W. Mendenhall,et al.  T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. , 1993, International journal of radiation oncology, biology, physics.

[15]  S Schraub,et al.  Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  C. Terhaard,et al.  The importance of vocal cord mobility in T2 laryngeal cancer. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  S. Stringer,et al.  Is elective neck treatment indicated for T2N0 squamous cell carcinoma of the glottic larynx? , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  G. Fletcher,et al.  T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. , 1988, International journal of radiation oncology, biology, physics.

[19]  W. F. Van den Bogaert,et al.  The significance of extension and impaired mobility in cancer of the vocal cord. , 1983, International journal of radiation oncology, biology, physics.

[20]  B. Cummings,et al.  T2 glottic cancer: an analysis of dose-time-volume factors. , 1981, International journal of radiation oncology, biology, physics.

[21]  G. Deboer,et al.  Prognostic factors in T2 glottic cancer , 1980, Cancer.

[22]  E. Fluur,et al.  XXV Aspects on Treatment of Cancer of the Larynx , 1967, The Annals of otology, rhinology, and laryngology.

[23]  F. Darrow,et al.  Carcinoma of the larynx. , 1949, The Journal of the Oklahoma State Medical Association.